EN
HI
Summary
As of 1 Nov, 2026, Jagsonpal Pharmaceuticals stock price is ₹242.4. During the trading session, the stock has moved between an intraday low of ₹0.00 and an intraday high of ₹0.00. Over the last 52 weeks, Jagsonpal Pharmaceuticals has traded between ₹155.00 and ₹264.50.
The stock has recorded a trading volume of 0 shares,. Its Average Traded Price (ATP) is ₹0.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 16 @ ₹242.40.
Jagsonpal Pharmaceuticals has an upper circuit limit of ₹259.30 and a lower circuit limit of ₹172.88. The total value traded stands at ₹0.00, and the delivery percentage for the day is 26.11%.
The stock is currently traded with a market lot size of 1. Jagsonpal Pharmaceuticals also offers a dividend yield of 2.54%.
Jagsonpal Pharmaceuticals Share Price Chart
Jagsonpal Pharmaceuticals Share Key Metrics
Volume
0.00
Market Cap
1596.57 CR
LTQ@LTP
16@242.40
ATP
0
Var Margin
19.57 %
Circuit Range
172.88-259.3
Delivery %
26.11 %
Value
0.00
ASM/GSM
No
Market Lot
1
Jagsonpal Pharmaceuticals Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
2.54
Sector P/E
39.15
Sector P/B
3.23
Sec. Div. Yield
0.54
Jagsonpal Pharmaceuticals Resistance and Support
Pivot 221.58
Resistance
First Resistance
232.16
Second Resistance
242.39
Third Resistance
252.97
Support
First Support
211.35
Second Support
200.77
Third Support
190.54
Jagsonpal Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 30 2026 | 222 | 216.09 | -2.64% | 226.64 | 212.58 |
| Thu Oct 29 2026 | 219.52 | 221.94 | -3.91% | 231.8 | 211 |
| Wed Oct 28 2026 | 225.1 | 230.96 | 3.52% | 239 | 222 |
Jagsonpal Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-28 | Quarterly Results |
| 2026-07-29 | Quarterly Results |
| 2026-04-27 | Audited Results & Final Dividend |
| 2026-03-12 | Buy Back of Shares |
| 2026-01-21 | Quarterly Results |
| 2025-11-03 | Quarterly Results |
| 2025-07-26 | Quarterly Results |
| 2025-05-06 | Audited Results & Final Dividend |
| 2025-01-22 | Quarterly Results |
| 2024-10-23 | Quarterly Results & Stock Split |
| 2024-08-07 | Quarterly Results |
Jagsonpal Pharmaceuticals News
Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Jagsonpal Pharmaceuticals reported Q2 FY27 cons. revenue of Rs.96.4 crore, marking a 29% YoY growth, with a net profit of Rs.12.3 crore. The performance was driven by a 9.3% rise in the standalone business and the strategic consolidation of Aequitas Healthcare.
Oct 28 2026 18:41:36
Jagsonpal Pharmaceuticals Ltd - 507789 - Board Meeting Outcome for Outcome Of Board Meeting
Jagsonpal Pharmaceuticals reported Q2 FY27 cons. revenue of ₹96.37 crore and net profit of ₹12.29 crore. The company also announced the acquisition of an 85% stake in Aequitas Healthcare for ₹20.80 crore and a pact to acquire the Wellness Portfolio of Group Pharmaceuticals.
Oct 28 2026 18:09:35
Read More
Jagsonpal Pharmaceuticals Management
| Name | Position |
|---|---|
| Pratham Rawal | Company Secretary & Compliance Officer |
| Harsha Raghavan | Chairperson |
Jagsonpal Pharmaceuticals Similar Stocks
Windlas Biotech Ltd.
1131.00
207.60 (22.48%)
Venus Remedies Ltd.
0.00
0.00 (0.00%)
NGL Fine-Chem Ltd.
2900.00
287.20 (10.99%)
Suraksha Diagnostic Ltd.
332.10
12.55 (3.93%)
Krsnaa Diagnostics Ltd.
562.00
64.05 (12.86%)
Amrutanjan Health Care Ltd.
502.00
8.80 (1.78%)
Gujarat Kidney And Super Speciality Ltd.
173.00
1.13 (0.66%)
KMC Speciality Hospitals (India) Ltd.
138.50
-10.86 (7.27%)
Shalby Ltd.
152.51
30.55 (25.05%)
Bharat Parenterals Ltd.
1550.00
-362.60 (18.96%)
Jagsonpal Pharmaceuticals FAQs
The Buying Price of Jagsonpal Pharmaceuticals share is 242.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Jagsonpal Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Jagsonpal Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Jagsonpal Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Jagsonpal Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Jagsonpal Pharmaceuticals’s valuation compare Sector P/E, P/B which are 39.15 & 3.23 with sector averages, along with growth rates and financial metrics.
The Market Cap of Jagsonpal Pharmaceuticals is 1596.57 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Jagsonpal Pharmaceuticals share price is 264.50 & 155.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Jagsonpal Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in JAGSNPHARM
Or Download Choice FinX App
Invest in JAGSNPHARM
